CN119894500A - 药物组合物 - Google Patents

药物组合物 Download PDF

Info

Publication number
CN119894500A
CN119894500A CN202380065197.4A CN202380065197A CN119894500A CN 119894500 A CN119894500 A CN 119894500A CN 202380065197 A CN202380065197 A CN 202380065197A CN 119894500 A CN119894500 A CN 119894500A
Authority
CN
China
Prior art keywords
composition
ketamine
stabilizer
amount
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380065197.4A
Other languages
English (en)
Chinese (zh)
Inventor
里娜·帕特尔
迪尼什·尚蒂拉尔·帕特尔
萨钦·迪内希·帕特尔
沙希坎特·普拉布达斯·库兰尼
米利德·维纳亚克·萨特
苏尔贾纳拉扬·曼德尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CN119894500A publication Critical patent/CN119894500A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN202380065197.4A 2022-09-22 2023-09-22 药物组合物 Pending CN119894500A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202221054235 2022-09-22
IN202221054235A IN202221054235A (https=) 2022-09-22 2022-09-22
PCT/IB2023/059391 WO2024062443A1 (en) 2022-09-22 2023-09-22 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
CN119894500A true CN119894500A (zh) 2025-04-25

Family

ID=88505108

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380065197.4A Pending CN119894500A (zh) 2022-09-22 2023-09-22 药物组合物

Country Status (4)

Country Link
EP (1) EP4590277A1 (https=)
CN (1) CN119894500A (https=)
IN (1) IN202221054235A (https=)
WO (1) WO2024062443A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025160542A1 (en) * 2024-01-26 2025-07-31 Inesket Llc Ketamine nasal spray formulation and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4312016A1 (de) * 1993-04-13 1994-10-20 Goedecke Ag Stabile Ketamin-Lösungen
EP1951248A4 (en) * 2005-11-14 2011-05-25 Peter D Winch NEW COLORED SOLUTIONS OF INJECTABLE MEDICINAL PRODUCTS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
CN121489917A (zh) * 2019-05-15 2026-02-10 贝克森生物医药公司 用于皮下注射的氯胺酮制剂
GB2596592A (en) 2020-07-03 2022-01-05 Alkaloid Ad Skopje Pharmaceutical formulation
WO2022109050A1 (en) 2020-11-18 2022-05-27 Bexson Biomedical, Inc. Complexing agent salt formulations of pharmaceutical compounds

Also Published As

Publication number Publication date
EP4590277A1 (en) 2025-07-30
IN202221054235A (https=) 2023-11-03
WO2024062443A1 (en) 2024-03-28

Similar Documents

Publication Publication Date Title
TWI772659B (zh) 醫藥配方
KR20040095352A (ko) 프로포폴의 수용성 프로드럭을 함유하는 약제학적 조성물및 그것을 투여하는 방법
JP7397910B2 (ja) 一酸化窒素放出プロスタミドを含有する眼科用組成物
JP6818019B2 (ja) レファムリンの注射可能医薬組成物
JP6935393B2 (ja) セバコイルジナルブフィンエステルの徐放のための医薬製剤
CN119894500A (zh) 药物组合物
KR102812226B1 (ko) 데옥시콜릭산을 포함하는 약제학적 조성물
US20140187520A1 (en) Stable injectable pharmaceutical composition of vitamin d receptor agonist and process for preparation thereof
EP3441073B1 (en) Medicinal composition comprising fulvestrant
US20100069315A1 (en) Method and medicament for treating ocular infections
EP3369422A1 (en) External preparation
WO2017132243A1 (en) Aqueous pharmaceutical formulation comprising propofol
RU2781022C2 (ru) Офтальмологические композиции, содержащие простамид, высвобождающий окись азота
US7645765B2 (en) Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
CN121969353A (zh) 一种溶液型喹硫平经鼻给药的组合物及其应用
CN121588032A (zh) 一种储库型局麻药缓释组合物及其制备方法和应用
WO2024095053A1 (en) Novel non-oral formulations of factor xa inhibitors and process for preparation thereof
HK40013822B (en) Ophthalmic compositions containing a nitric oxide releasing prostamide
HK40013822A (en) Ophthalmic compositions containing a nitric oxide releasing prostamide
HK40018890B (en) Ophthalmic compositions containing a nitric oxide releasing prostamide
HK40018890A (en) Ophthalmic compositions containing a nitric oxide releasing prostamide
KR20260057219A (ko) 4-(7-히드록시-2-이소프로필-4-옥소-4h-퀴나졸린-3-일)-벤조니트릴의제형
KR20150027160A (ko) 척추 투여용 과포화 아세타미노펜 주사 용액
HK1243932B (zh) 药物制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination